Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...
Main Authors: | López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
MDPI
2019
|
פריטים דומים
-
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
מאת: César López-Camacho, et al.
יצא לאור: (2019-11-01) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
מאת: Moorthy, V, et al.
יצא לאור: (2003) -
New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
מאת: Alharbi, N
יצא לאור: (2014) -
Clinical development of Modified Vaccinia virus Ankara vaccines.
מאת: Gilbert, S
יצא לאור: (2013) -
Clinical development of Modified Vaccinia virus Ankara vaccines
מאת: Gilbert, S
יצא לאור: (2013)